ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Grünenthal GmbH clinical trials

Its pipeline, or its studies — you choose. Free with an account during the beta.

The registry lists 93 studies whose lead sponsor is Grünenthal GmbH or one of 5 companies grouped under it. 3 are recruiting or about to start. Per ClinicalTrials.gov, last updated Nov 17, 2026.

Our grouping of 6 registry names, not the registry’s. See them and correct one ↓

Compare Grünenthal with Vertex Pharmaceuticals and Jiangsu HengRui Medicine →

Pipeline: 3 programs

Each counted once: 3 with a study Grünenthal GmbH leads registered in the last two years.

  • Phase 1
  • Phase 2

The 3 programs — sign in to see the list, free: with every program, filter by condition or phase and sort by first study or primary completion.

“Registry” is the highest phase of Grünenthal GmbH’s own registered studies; Grünenthal GmbH’s own pipeline document is not read yet. “Primary completion” is the earliest date still ahead among its live studies when the main measure’s data collection ends, as the registry states it (most are estimates); results come later, if they are announced. Programs are read from ClinicalTrials.gov, joined across names by rules and decisions each recorded with its evidence.

What it is testing

The drugs Grünenthal GmbH’s studies test, most open studies first — 33 drugs with a page of their own. Each count opens the studies in search.

Open now Not open: under way, finished or stopped

Show 20 more

The first 30 of 33; every drug is on its own page, and each page lists its sponsors.

Coming up

2 of Grünenthal GmbH’s studies under way reach primary completion within a year. The dates are the sponsor’s own estimates, which often move.

Phase 3 Other phases

  1. N’26
  2. D
  3. J’27
  4. F
  5. 1M
  6. A
  7. M
  8. J
  9. J
  10. A
  11. 1S
  12. O
  13. N

Add all 2 to your calendar (.ics) → With an account.

What changed recently

From the registry's own updates since Oct 19, 2026.

All 93 at a glance

Where each study is in its life, its phase and its countries. Each count opens them in search.

  • Open now33%Not yet recruiting 2 · Recruiting 1
  • Under way, not recruiting22%
  • Completed6873%
  • Stopped early2022%Terminated 16 · Withdrawn 4

Phase

  • Phase 149
  • Phase 327
  • Phase 214
  • Phase 43

Where

  • Germany27
  • United States22
  • United Kingdom17
  • Poland17
  • Chile16
  • France15

Over the years

  1. 907
  2. 08
  3. 09
  4. 10
  5. 11
  6. 12
  7. 13
  8. 14
  9. 15
  10. 16
  11. 17
  12. 18
  13. 19
  14. 20
  15. 21
  16. 22
  17. 23
  18. 24
  19. 25
  20. 526

By the year each study started; 17 started before 2007. 2026 so far in the lighter column.

Registry sponsor names on this page

Our grouping. This page groups the registry's lead sponsor names by company — our grouping, not the registry's. It can be wrong or incomplete: an acquired company whose name never mentions its owner may be missing. Use “Something wrong?” under any name below to correct it.

Tell us about a missing company
No account needed. Please leave out personal details.

Each name exactly as ClinicalTrials.gov lists it, and how it relates to Grünenthal GmbH.

  • Grünenthal GmbH
    Same company
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    69 studies
  • Laboratorios Andromaco S.A.
    Acquired — became part of Grünenthal GmbH, Dec 2013 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    19 studies →
  • Averitas Pharma, Inc.
    Acquired — became part of Grünenthal GmbH, 2018 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    2 studies →
  • Valinor Pharma LLC
    Acquired — became part of Grünenthal GmbH, 2024 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Thar Pharmaceuticals, Inc
    Acquired — became part of Grünenthal GmbH, 2016 · source ↗
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →
  • Grünenthal Colombiana S.A.
    Regional office
    Something wrong?
    What is wrong with this name?
    No account needed. Please leave out personal details.
    1 study →

Focus areas

Conditions Grünenthal GmbH leads ten or more studies in, by study count. A broader condition is left out when almost all its studies are already in a narrower one listed here.

Studies

Recruiting first, then most recently updated. Showing 50 of 93. Browse all 93 →